AZD0780 - PCSK9i in daily pill form

An investigational drug (AZD0780) shows success in phase 2b trials. Hopefully it will pass further trials and be approved before too long.

https://www.medscape.com/viewarticle/new-pcsk9-gets-cholesterol-target-if-statins-cant-2025a1000932

New PCSK9 Gets Cholesterol to Target if Statins Can’t

4 Likes